LISA ANGEL: Open Payments
NPI 1073282992 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 22 payments from 13 companies in 2025. Trend: 2023 $65 · 2024 $648 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $61 |
| Insulet Corporation | 3 | $56 |
| Amgen Inc. | 3 | $55 |
| Sequel Med Tech, LLC | 2 | $41 |
| Abbott Laboratories | 2 | $39 |
| BETA BIONICS, INC. | 2 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Verity Pharmaceuticals Inc. | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| CeQur Corporation | 1 | $21 |
Products named: Omnipod, TWIIST, EVENITY, FREESTYLE LIBRE 3, iLet Bionic Pancreas, Wegovy, TRYNGOLZA, Ozempic.
Industry payments across KY — which companies pay providers there.
